Aflibercept Traps Galectin-1, an Angiogenic Factor Associated with Diabetic Retinopathy
about
Diabetic macular oedema: evidence-based treatment recommendations for Asian countries.Galectin-1 expression imprints a neurovascular phenotype in proliferative retinopathies and delineates responses to anti-VEGFFundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti-vascular endothelial growth factor therapy of macular diseasesRNA Sequencing Reveals that Kaposi Sarcoma-Associated Herpesvirus Infection Mimics Hypoxia Gene Expression Signature.Suppression of Retinal Neovascularization by Inhibition of Galectin-1 in a Murine Model of Oxygen-Induced Retinopathy.Non-responsiveness to intravitreal aflibercept treatment in neovascular age-related macular degeneration: implications of serous pigment epithelial detachment.Advanced glycation endproducts link inflammatory cues to upregulation of galectin-1 in diabetic retinopathy.Management of diabetic macular edema in Japan: a review and expert opinion.Effects of Intravitreal Aflibercept on Galectin-1 and Vascular Endothelial Growth Factor-A Plasma Levels in Patients with Diabetic Retinopathy.Aflibercept in the treatment of diabetic macular edema: a review and consensus paper.Retinal and choroidal angiogenesis: a review of new targets.Galectin-1 enhances TNFα-induced inflammatory responses in Sertoli cells through activation of MAPK signalling.Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY Substudy
P2860
Q30101045-5618997A-CC4B-4893-B724-EE89434276F4Q33779141-B2EB7A4E-75E4-4945-848A-0CC9E73DE67BQ33840787-1A546E18-60E0-4AB7-A438-C16C9C5310FFQ36238539-552CDCA7-0818-419E-86A0-2A452F572427Q37744139-57012B36-1A81-48D8-8251-D939F25F4321Q42426609-90A1E054-D0B3-4FE2-9DA8-BEC51CB52CD6Q47121856-272B52F5-A46C-46AE-A5EA-CE2CB835F847Q48579709-21A2BA26-46E3-45C3-B179-2DF4DC1CEAFBQ49667627-647D614E-61E7-4558-B0C2-073812DAD98DQ50095639-CF9738B2-1AD9-4796-BA92-FF64606A23CDQ53098522-FB17DFDE-EFAA-4261-B2B6-9BD145D62FA5Q55155726-E607987B-D6E3-4F03-A651-1B252A6DFA1AQ58130274-530379E0-FF74-421A-A7BA-EA55AC60A0AE
P2860
Aflibercept Traps Galectin-1, an Angiogenic Factor Associated with Diabetic Retinopathy
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Aflibercept Traps Galectin-1, an Angiogenic Factor Associated with Diabetic Retinopathy
@ast
Aflibercept Traps Galectin-1, an Angiogenic Factor Associated with Diabetic Retinopathy
@en
type
label
Aflibercept Traps Galectin-1, an Angiogenic Factor Associated with Diabetic Retinopathy
@ast
Aflibercept Traps Galectin-1, an Angiogenic Factor Associated with Diabetic Retinopathy
@en
prefLabel
Aflibercept Traps Galectin-1, an Angiogenic Factor Associated with Diabetic Retinopathy
@ast
Aflibercept Traps Galectin-1, an Angiogenic Factor Associated with Diabetic Retinopathy
@en
P2093
P2860
P356
P1433
P1476
Aflibercept Traps Galectin-1, an Angiogenic Factor Associated with Diabetic Retinopathy
@en
P2093
Atsuhiro Kanda
Kousuke Noda
Susumu Ishida
P2860
P2888
P356
10.1038/SREP17946
P407
P50
P577
2015-12-09T00:00:00Z